PT  - JOURNAL ARTICLE
AU  - Pines, Jesse M.
AU  - Zocchi, Mark S.
AU  - Black, Bernard S.
AU  - Kornas, Rebecca
AU  - Celedon, Pablo
AU  - Moghtaderi, Ali
AU  - Venkat, Arvind
AU  - ,
TI  - How the COVID-19 pandemic has adversely affected the economics of U.S. emergency care
AID  - 10.1101/2020.12.12.20248102
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.12.12.20248102
4099  - http://medrxiv.org/content/early/2020/12/14/2020.12.12.20248102.short
4100  - http://medrxiv.org/content/early/2020/12/14/2020.12.12.20248102.full
AB  - Objective We describe how the coronavirus (COVID-19) pandemic impacted emergency department (ED) economics, acuity, and staffing.Methods We conducted an observational study of visits during January to September 2020 compared to 2019 in 136 EDs staffed by a national emergency medicine group. We created ratios of three-week moving averages for 2020 visits, acuity, costs divided by 2019 moving averages, by age and ED size. We tabulated reductions in clinician hours and FTEs compared to early 2020 staffing.Results 2020-2019 ED visit ratios declined in March nadiring mid-April for both adults (to 0.60) and children (to 0.30) and rose thereafter but remained below 2019 levels through September 2020. The ratio of adult RVUs/visit rose to 1.1 for adults and 1.2 for children in the early pandemic, falling to 1.04 and 1.1 through September. The ratio of direct salary expenses in freestanding (FSED) and small EDs declined less dramatically than in medium and large EDs. Clinical revenues in medium and large EDs declined more sharply and recovered slowly but plateaued well below 2019 levels. By September 2020, expenses were still higher than revenues for small EDs, similar for FSEDs, and somewhat higher for medium and large EDs. During the pandemic, physician hours fell 15% and APP hours 27% during COVID-19 translating to 174 lost physician and 193 lost APP FTEs.Conclusion The COVID-19 pandemic reduced ED visits and increased acuity in the first 7 months of the pandemic, leading to a contraction of the ED workforce, and threatening ED economics, more so in small and FSEDs.Competing Interest StatementJMP has been a consultant to CSL Behring, Abbott Point-of-Care, Beckman Coulter, and Novo Nordisk for unrelated work.Funding StatementThere was no funding for this studyAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Approved by Allegheny Health Network IRBAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data referred to in this study are not publicly available.